top of page

PRECLINICAL & CLINICAL SERVICES

ai generated image

Preclinical and Clinical Services

Mumbai Biocluster supports the development pipeline through preclinical and clinical services, including in vitro and in vivo studies. They work closely with industry partners to provide data-driven insights that accelerate the clinical trial process and enhance drug safety profiles.

Science Lab

Our Services Includes

01

DS/DP for Safety/Tox Studies

  • GMP and Non-GMP Manufacturing of Drug Substance (DS)

  • Analytical Method Development and Validation

  • Supply Chain Management and Logistics for Preclinical Studies

03

Stability Studies for Preclinical Batches

  • Stability studies on clinical-stage products to assess their shelf life, potency, and safety under various storage conditions.

  • Long-term, accelerated, and stress testing, along with providing GMP-compliant storage solutions for clinical materials.

02

Clinical Stage Manufacturing

  • GMP Manufacturing of Clinical Batches

  • Scale-Up and Technology Transfer

  • Aseptic Fill-Finish Services

  • Stability Studies and Storage

  • Regulatory Documentation and Support

04

Formulation Development for Preclinical Studies

  • Formulation development services tailored to the needs of safety and toxicology studies.

  • Creation of stable, bioavailable formulations that can be used in animal studies to assess the safety profile of the drug candidate.

Ict Mumbai Logo
Biocluster Logo

ICT Mumbai Research Foundation is set to catalyze innovation in biopharmaceuticals by serving as an accelerator for startups, academia, MSMEs, and industries, providing state-of-the-art infrastructure and expertise for accelerated development of critical therapies for diseases like cancer, rare diseases, and infectious diseases. 

Quick Links

©2024 by MUMBAI BIOCLUSTER. Proudly created in Mumbai

Get In Touch

+91 81690 53794

Institute of Chemical Technology,
Nathalal Parekh Marg, near Khalsa College, Matunga East, Mumbai, Maharashtra 400019

  • Instagram
  • Twitter
  • LinkedIn
bottom of page